- This event has passed.
National workshop: From diagnosis of cancer to diagnosis of Lynch syndrome
November 10 2021 @ 1:00 PM - 2:00 PM
|Recurring Event (See all)
One event on November 29 2021 at 1:00 PM
Workshops focused around the roles and responsibilities of local cancer MDT members in the Lynch syndrome testing pathway.
Lynch syndrome (LS) is an inherited condition caused by pathogenic variants in DNA genes which result in an increased risk of colorectal, endometrial, and other cancers.
Increases risk of developing bowel cancer to up to 80%
Previously called hereditary non-polyposis colorectal cancer (HNPCC).
LS affects approximately 1 in 300-1 in 400 people, with 200,000-300,000 people likely to have this condition in the UK. It is estimated that only 5% of people with LS have been diagnosed with this condition.
NICE guidelines recommend universal testing for LS in people with colorectal (CRC) [DG27] and endometrial cancer [DG42].
Kevin Monahan, Consultant Gastroenterologist at St Mark’s Hospital and Co-Chair of the national NHS GMS Lynch Syndrome Oversight Group
Adam Shaw, Consultant Geneticist at Guy’s and St Thomas’ and Co-Chair of the national NHS GMS Lynch Syndrome Oversight Group